Professor Eric Lim

Professor Eric Lim

Consultant Thoracic Surgeon · Royal Brompton Hospital

Professor of Thoracic Surgery at Imperial College London and a leading figure in minimally invasive lung cancer surgery — dedicated to operations that cause the least possible pain and disruption to a patient's life.

130+Peer-reviewed publications
2007Consultant at Royal Brompton
2Award-winning textbooks

A Career Dedicated to Patients

Professor Eric Lim studied medicine at the University of Sheffield and trained in cardiothoracic surgery at Papworth Hospital, Cambridge and the Royal Brompton Hospital, London.

A recipient of a UK Medical Research Council scholarship, he was awarded an MSc in Medical Statistics and a Doctorate of Medicine (MD) for surgical research. He joined the Royal Brompton Hospital in 2007 as a consultant thoracic surgeon, where he leads the academic division of thoracic surgery and the Biomedical Research Unit Cancer Consortia.

He pioneered the single-incision keyhole surgery programme for lung cancer at Royal Brompton — today the majority of his operations are performed through a single 3 cm incision, many as day-case procedures.

EnglishMandarin
Professor Eric Lim and his thoracic surgery team

Professor Lim with his thoracic surgery team.

Clinical Expertise

Minimally Invasive Surgery

Single-incision (uniportal VATS) keyhole surgery for lung cancer — less pain, faster recovery, shorter hospital stays.

Complex Cancer Surgery

Surgery for advanced lung cancer, including airway and blood vessel reconstruction to preserve as much healthy lung as possible.

Day-Case Procedures

Day-case surgery for pleural effusion, pneumothorax and mediastinal conditions.

Second Opinions

Authoritative assessment for patients declined surgery elsewhere or considered too high risk.
  • VATS lobectomy & lung resection
  • Sleeve resections
  • Airway surgery
  • Arterial reconstructions
  • Mediastinal tumours (benign & malignant)
  • Neuroendocrine & small cell lung cancer surgery
  • Lung volume reduction for emphysema
  • Pleural effusions
  • Pneumothorax
  • Lung cancer screening

Research & Clinical Trials

Professor Lim's translational research focuses on blood-based cancer diagnosis — circulating tumour cells and cell-free DNA/RNA — aspiring to shorten the time to diagnosis and eliminate the complications of invasive tissue biopsy.

His work on systematic reviews and clinical trials in thoracic surgery won the Society for Cardiothoracic Surgery prize for best thoracic surgery research four consecutive years (2008–2011).

MARS 2 — Chief Investigator

UK multicentre randomised trial of surgery (pleurectomy decortication) for mesothelioma.

VIOLET — Chief Investigator

UK multicentre trial of VATS lobectomy versus open surgery for lung cancer.
"I aspire to make thoracic surgery cause the least amount of pain and disruption to the patient's life as possible." Professor Eric Lim

Publications & Books

An Integrated Textbook of Medicine and Surgery — Editor

Elsevier · A pioneering textbook linking two traditionally separate specialties. Highly Commended, BMA Book Awards 2008; Highly Commended, Royal Society of Medicine & Royal Society of Authors 2008; Highly Commended, NHS Innovations Awards 2008.

Churchill's Pocketbook of Differential Diagnosis — Editor

Now in its fourth English edition, also translated into Greek and Russian.

130+ Peer-Reviewed Publications & 6 Book Chapters

Spanning surgical oncology, biomarker development and validation in lung cancer, systematic reviews and clinical trials. Full list available on PubMed.

Leadership & Recognition

  • Chair, British Thoracic Society / SCTS Guidelines on the Radical Management of Lung Cancer
  • Chair, UK Thoracic Surgery Research Collaborative
  • Member, 9th TNM Staging Committee for Lung Cancer
  • Deputy Statistics Editor, Journal of Thoracic and Cardiovascular Surgery
  • Associate Editor, Thorax
  • 2020 Robert J. Ginsberg Lectureship Award — IASLC
  • Council member, European Society of Thoracic Surgeons
  • Member, ESMO Guidelines for Early-stage Lung Cancer
  • Steering Committee, British Thoracic Oncology Group
  • Panel member, UK Intercollegiate Specialty Board in Cardiothoracic Surgery